Form D · Other
Cytodyme, Inc.
San Diego, CA · CIK 0002108897
Offering snapshot reported Feb 9, 2026 · SEC filing
- Reported sold
- $75K Offering amount: $2.5M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 13, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 9, 2026 | Initial | $75,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-572938
Simple Agreement for Future Equity
Source: Form D, filed Feb 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Stephen Brown Bourne | Director, Executive |
| Tammy Ogden | Director, Executive |
| Dennis White | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
10476 Newbliss Way
San Diego, CA, 92126
San Diego, CA, 92126